Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

TPLC - Total Product Life Cycle
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search show TPLC since Back to Search Results
Device fibrinogen and fibrin split products, antigen, antiserum, control
Regulation Description Fibrinogen/fibrin degradation products assay.
Product CodeDAP
Regulation Number 864.7320
Device Class 2

MDR Year MDR Reports MDR Events
2021 7 7
2022 30 30
2023 4 4
2024 1 1
2025 2 2
2026 1 1

Device Problems MDRs with this Device Problem Events in those MDRs
Unable to Obtain Readings 12 12
Nonstandard Device 11 11
Incorrect, Inadequate or Imprecise Result or Readings 4 4
Low Test Results 4 4
False Negative Result 3 3
False Positive Result 3 3
Non Reproducible Results 2 2
Manufacturing, Packaging or Shipping Problem 2 2
Use of Device Problem 2 2
Device Markings/Labelling Problem 1 1
Installation-Related Problem 1 1

Patient Problems MDRs with this Patient Problem Events in those MDRs
No Clinical Signs, Symptoms or Conditions 40 40
Insufficient Information 2 2
Hypersensitivity/Allergic reaction 1 1
No Patient Involvement 1 1
Laceration(s) 1 1

Recalls
Manufacturer Recall Class Date Posted
1 Diagnostica Stago, Inc. II Mar-19-2026
2 Diagnostica Stago, Inc. II Oct-16-2025
3 GET TESTED INTERNATIONAL AB II Dec-01-2025
4 bioMerieux, Inc. II Dec-28-2021
-
-